Clinical Trial Update: Hyperpolarized Xenon MRI for Assessment of Pulmonary Function in Lung Transplant [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating hyperpolarized xenon MRI for assessing pulmonary function in lung transplant patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Transplant Complications
• Pulmonary Disease in Lung Transplant Recipients
• Pulmonary Surgical Procedures

Snippet

Sponsor: Polarean, Inc. | Conditions: Pulmonary Surgical Procedures | Phase 3 | Status: COMPLETED